Cargando…
Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
Oncolytic viruses have been seriously considered for glioma therapy over the last 20 years. The oncolytic activity of several oncolytic strains has been demonstrated against human glioma cell lines and in in vivo xenotransplant models. So far, four of these stains have additionally completed the fir...
Autores principales: | Koks, Carolien A.E., De Vleeschouwer, Steven, Graf, Norbert, Van Gool, Stefaan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317755/ https://www.ncbi.nlm.nih.gov/pubmed/25663937 http://dx.doi.org/10.7150/jca.10640 |
Ejemplares similares
-
Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma
por: Vandenberk, Lien, et al.
Publicado: (2014) -
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
por: Vandenberk, Lien, et al.
Publicado: (2015) -
Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020) -
Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice
por: Soldozy, Sauson, et al.
Publicado: (2023) -
Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
por: Bernstock, Joshua D, et al.
Publicado: (2023)